PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
Clinical trial NCT02288897 · TERMINATED
Trial details
- NCT number
- NCT02288897
- Sponsor
- Provectus Biopharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2019-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.